Ambrx Biopharma Cayman, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2019 to Q4 2022.
  • Ambrx Biopharma Cayman, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2022 was $4.73M, a 70.8% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $4.73M +$1.96M +70.8% Dec 31, 2022 10-K 2023-03-30
Q4 2021 $2.77M +$485K +21.3% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $2.28M +$309K +15.7% Dec 31, 2020 10-K 2023-03-30
Q4 2019 $1.97M Dec 31, 2019 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.